Key result
Curcumin attenuates post-MI cardiac fibrosis and fibroblast activation via SIRT1 signaling in preclinical models.
Answers are grounded in this paper and cite their sources.
Curcumin, a polyphenolic compound derived from turmeric, protects against myocardial injury by alleviating oxidative stress, inflammation, apoptosis, and fibrosis. However, the role of curcumin and its mechanism of action on interstitial fibrosis after myocardial infarction (MI) are poorly understood. To clarify, MI was induced by a permanent ligation of the left anterior descending coronary artery in adult mice, and the effects of curcumin were evaluated 4 weeks after the MI event. In vitro, we treated cardiac fibroblasts (CFs) with Ang II, and investigated the anti-fibrotic mechanism of curcumin. Our results showed that curcumin significantly attenuated collagen deposition in vivo and inhibited CF proliferation and migration, and MMP expression. In addition, we found that the down-regulation of SIRT1 after MI was attenuated by curcumin pretreatment, which indicated that the activation of SIRT1 might be involved in the protective action of curcumin. This hypothesis was confirmed by genetic inhibition of SIRT1 (siRNA-SIRT1) in Ang II-treated CFs. Our results provide new insights into the mechanism underlying the anti-fibrotic effects of curcumin in the heart.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2016) studied Myocardial infarction-induced cardiac fibrosis. Curcumin was evaluated on Collagen deposition in vivo and cardiac fibroblast proliferation, migration, and MMP expression in vitro. Curcumin significantly attenuated collagen deposition at 4 weeks post-MI in mice and inhibited cardiac fibroblast proliferation, migration, and MMP expression via SIRT1 activation.
Synapse has enriched 10 related papers. Consider them for comparative context: